BioSpace News Archive

In our role as a U.S. Healthcare Provider, Armas Pharmaceuticals Inc. (Armas) is working diligently with our international partners during the current global health emergency.

Arcutis Biotherapeutics, Inc. announced that, at the request of the U.S. Food and Drug Administration, Arcutis has submitted a protocol amendment to the FDA to include children ages 2 to 11 years old in the Company’s on-going DERMIS-1 and DERMIS-2 pivotal Phase 3 clinical trials evaluating topical roflumilast cream as a potential topical treatment for plaque psoriasis.

Spero Therapeutics, Inc. today announced financial results for the fourth quarter and full-year ended December 31, 2019 and provided a pipeline update.

Diamond Equity Research, an equity research firm with a focus on micro capitalization and small capitalization public companies has released a comprehensive update note of Hoth Therapeutics, Inc..

Medical Home Network’s community-based care teams proactively reach out to high risk individuals to offer help

Predictive Oncology Inc. (NASDAQ: POAI) (“Predictive Oncology” or “the Company”), a data and artificial intelligence (“AI”) driven discovery services company that provides predictive models of tumor drug response to improve clinical outcomes for patients, today announced that it has entered into a securities purchase agreement with certain accredited investors to raise $3.5 million through the issuance of up to 1,650,165 shares of common stock

Endologix® Inc. (Nasdaq: ELGX) (“Endologix” or the “Company”), a developer and marketer of innovative treatments for aortic disorders, today announced that it has received approval from the United States Food and Drug Administration (FDA) for the Alto™ Abdominal Stent Graft System (Alto).

DermTech, Inc. (NASDAQ: DMTK) (“DermTech”), a leader in precision dermatology enabled by a non-invasive skin genomics platform, today announced that SKIN, the official journal of the National Society for Cutaneous Medicine, has published data showing that combining TERT DNA mutation analyses with DermTech’s Pigmented Lesion Assay (the “DermTech PLA”) improved the test sensitivity for detecting melanoma to 97%, up from a sensitivity of 91% without TERT.

Mango Sciences, Inc., a leading data science company focused on emerging markets, today announced how it plans to understand, manage, and solve the health challenges of underrepresented populations to enable precision medicine for billions of consumers.

Olympus, a global technology leader in designing and delivering innovative solutions for medical procedures, among other core businesses, announced today that an updated guidance from the Food and Drug Administration (FDA) mandates that laparoscopic power morcellation in gynecological procedures be conducted with an approved containment device.